Gaggini et al. [35] analyzed AA profiles in addition to the measurement of euglycemic insulin clamp IR indices in subjects with NAFLD without diabetes and healthy control subjects and developed a new glutamate–serine–glycine (GSG) index (glutamate/(serine + glycine)). The gene discussed is INS; the disease is metabolic dysfunction-associated steatotic liver disease.